347 related articles for article (PubMed ID: 12639220)
1. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor.
Deakin S; Leviev I; Brulhart-Meynet MC; James RW
Biochem J; 2003 Jun; 372(Pt 2):643-9. PubMed ID: 12639220
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin.
Deakin S; Guernier S; James RW
Pharmacogenet Genomics; 2007 Jun; 17(6):451-7. PubMed ID: 17502837
[TBL] [Abstract][Full Text] [Related]
3. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
[TBL] [Abstract][Full Text] [Related]
4. High glucose induces transactivation of the human paraoxonase 1 gene in hepatocytes.
Ikeda Y; Suehiro T; Arii K; Kumon Y; Hashimoto K
Metabolism; 2008 Dec; 57(12):1725-32. PubMed ID: 19013297
[TBL] [Abstract][Full Text] [Related]
5. Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene.
Ota K; Suehiro T; Arii K; Ikeda Y; Kumon Y; Osaki F; Hashimoto K
Metabolism; 2005 Feb; 54(2):142-50. PubMed ID: 15690306
[TBL] [Abstract][Full Text] [Related]
6. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon.
Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
Br J Pharmacol; 1997 Sep; 122(2):265-8. PubMed ID: 9313934
[TBL] [Abstract][Full Text] [Related]
7. Sp1 site is crucial for the mouse claudin-19 gene expression in the kidney cells.
Luk JM; Tong MK; Mok BW; Tam PC; Yeung WS; Lee KF
FEBS Lett; 2004 Dec; 578(3):251-6. PubMed ID: 15589828
[TBL] [Abstract][Full Text] [Related]
8. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
Xia T; Zeng G; Gao L; Yu RK
Gene; 2005 May; 351():109-18. PubMed ID: 15890474
[TBL] [Abstract][Full Text] [Related]
9. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
[TBL] [Abstract][Full Text] [Related]
11. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
[TBL] [Abstract][Full Text] [Related]
12. Structure of the human 5-HT7 receptor gene and characterization of its promoter region.
Laenen K; Haegeman G; Vanhoenacker P
Gene; 2007 Apr; 391(1-2):252-63. PubMed ID: 17321075
[TBL] [Abstract][Full Text] [Related]
13. Analysis of human UDP-glucose dehydrogenase gene promoter: identification of an Sp1 binding site crucial for the expression of the large transcript.
Vatsyayan J; Peng HL; Chang HY
J Biochem; 2005 Jun; 137(6):703-9. PubMed ID: 16002992
[TBL] [Abstract][Full Text] [Related]
14. Coordinate regulation of bovine prion protein gene promoter activity by two Sp1 binding site polymorphisms.
Xue G; Sakudo A; Kim CK; Onodera T
Biochem Biophys Res Commun; 2008 Aug; 372(4):530-5. PubMed ID: 18505676
[TBL] [Abstract][Full Text] [Related]
15. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.
Liu W; Innocenti F; Wu MH; Desai AA; Dolan ME; Cook EH; Ratain MJ
Cancer Res; 2005 Jan; 65(1):46-53. PubMed ID: 15665278
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase 1 gene promoter polymorphisms are associated with the extent of stenosis in coronary arteries.
Najafi M; Gohari LH; Firoozrai M
Thromb Res; 2009; 123(3):503-10. PubMed ID: 18433845
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma.
Yan Y; Dalmasso G; Sitaraman S; Merlin D
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G535-45. PubMed ID: 17023546
[TBL] [Abstract][Full Text] [Related]
18. Positive regulation of promoter activity of human 3-phosphoglycerate dehydrogenase (PHGDH) gene is mediated by transcription factors Sp1 and NF-Y.
Jun DY; Park HS; Lee JY; Baek JY; Park HK; Fukui K; Kim YH
Gene; 2008 May; 414(1-2):106-14. PubMed ID: 18378410
[TBL] [Abstract][Full Text] [Related]
19. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
[TBL] [Abstract][Full Text] [Related]
20. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells.
Liu J; Yang H; Liu W; Cao X; Feng X
J Cell Biochem; 2005 Nov; 96(4):716-27. PubMed ID: 16052479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
